
The importance of India’s health diplomacy
For long thought of as a net recipient of global health benefits, India is turning into a global healthcare provider. This will be a major pillar of its diplomacy in the years to come.
For long thought of as a net recipient of global health benefits, India is turning into a global healthcare provider. This will be a major pillar of its diplomacy in the years to come.
Apart from Covaxin and Sputnik V, companies based in the city are also involved in developing or manufacturing several other Covid-19 vaccines.
Market experts welcome the 30–stock benchmark adding 6,000 points since December 1, but also caution against stretched valuations.
Gold exchange traded funds added a record 877 tonnes during 2020, nearly 231 tonnes more than the 2009 record of 646 tonnes. Experts argue much of gold's growth drivers will continue in 2021 too.
While the government rolled out the Covid-19 vaccination programme on January 16, questions of accessibility and affordability remain for sections of the population.
India began the first phase of the mass vaccination programme against Covid-19. Fortune India's photo team visited one session site in Gurugram where the campaign was in full swing.
The massive campaign to deploy the Covid-19 vaccine rests on infrastructure, both physical and digital. Using past campaigns, India put together a multi-pronged strategy for a smooth roll-out.
For BBIL’s founder Krishna Ella, the roll-out of a made-in-India vaccine, Covaxin, is peppered with challenges. Two recent deals with Brazilian and American firms have now buoyed him.
The preparations on the ground are in full swing, and the country is using the expertise and insights culled from its innumerable election processes to begin rolling out the Covid-19 vaccine.
The U.K. has given its nod for the AstraZeneca-Oxford vaccine. Back in India, the country is readying for a massive immunisation campaign. Here's a close look at the programme.